Investigators found patients with acute coronary syndrome were 3 times more likely to die in the hospital. Patients with thrombotic thrombocytopenic purpura (TTP) face a higher risk of morbidity and ...
The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).